Funtleyder Leslie D. 4
4 · Applied Therapeutics, Inc. · Filed Feb 7, 2025
Insider Transaction Report
Form 4
Funtleyder Leslie D.
DirectorChief Financial Officer
Transactions
- Sale
Common Stock
2025-02-06$0.61/sh−22,950$14,000→ 404,961 total
Footnotes (1)
- [F1]The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of compensatory Restricted Stock Units. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the reporting person.